Category: TA-65

Real patient experiences

Will 49-yo Mark now have the life expectancy of a 19-yo Mark?

After two years of TA-65 use, his median length is now 12,500 (from an estimated 9,400) with a very nice drop in critically-short telomeres to 4.5% (from a baseline of up to 20%). So if you believe what most research is showing regarding the connection between shorter telomeres and longevity, Mark has gained over 30 years of longevity in a time where he should have lost three years.

Edward 06/01/2015 No Comments

Ovulation after menopause? – RN declines to explain to her MD

I do not follow a lot of conventional medical practices for myself. Medicine in very invasive now. I am 59 yo and in good health. I do not take any prescribed meds. I try to stay away from MDs as much as I can. Of course, I had to go when I had the bleeding – just to be sure.

Edward 05/30/2015 1 Comment

Dogs use oxytocin to bond with humans

It would seem that it’s a “dog-eat-dog” work amongst dogs but when they are looking to be adopted and cared for by humans, they have co-opted the infant-parent cuteness that keeps us from abandoning our own young.

Edward 04/17/2015 No Comments

Patients keep their good results secret

I was contacted last week by a client who has gotten his diabetes under control at the age of 73. He couldn’t be happier but based on his past negative experiences and his desire to maintain respectability as a partner in a prominent law firm, he doesn’t want to endorse me or TA-65 openly.

Edward 04/12/2015 No Comments

The NEW RECHARGE™ is now a 29% better value (but it is NOT ‘generic’ TA-65)

This week, I presented a live webinar on the topic of “TA-65 versus RECHARGE” in which I answered all your burning questions about TA-65 including a comprehensive review of the literature. I also discussed why RECHARGE is not the same as TA-65 and cannot be be marketed as a proven telomerase activator.

Edward 03/29/2015 3 Comments

TA-65 repairs telomeres without increasing cancer incidence in mice

For those wanting a more in-depth understanding of how TA-65 might work, I refer to you an email conversation I had with a patient, who was concerned that a blog referenced a Blasco paper demonstrating a 50% increase in liver cancer in mice after taking TA-65.

Edward 02/16/2015 2 Comments

Are you interested in
exosome treatments?

drop Me a line to learn more

DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.

Navigation

Subscribe to Dr. Park's weekly newsletter

Required fields

Exosomes and TA-65 are not FDA-approved to prevent or treat any illness